TIAA-CREF Individual & Institutional Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$310K	Buy	+1,339	New	+$331K	﹤0.01%	580

Other funds holding JAZZ

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's JAZZ Position: Q3 2026 in Review

TIAA-CREF Individual & Institutional Services opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 1,339 shares worth $310K. The stake represents ﹤0.01% of the portfolio and ranks #580 among its holdings.

538 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

TIAA-CREF Individual & Institutional Services held 1,339 shares of Jazz Pharmaceuticals worth $310K as of Q3 2026.
Jazz Pharmaceuticals was a new TIAA-CREF Individual & Institutional Services position in Q3 2026.
Jazz Pharmaceuticals made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q3 2026, its #580 holding.
538 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q3 2026, filed 12 Nov 2026.